Dr. Jan Martin Wicke appointed to the Board of Management of Talanx AG
- Dr. Wicke to assume responsibility in future for the Retail Germany Division and will succeed Dr. Heinz-Peter Roß
Dr. Wicke succeeds Dr. Heinz-Peter Roß, who will leave the Board of Management on 30 June 2014 when the term of his appointment expires.
"In Dr. Wicke we have attracted not only a proven expert for German retail business but also a strong leadership figure. We are looking forward to working with him and wish him every success and all the very best in his mission", Wolf-Dieter Baumgartl, Chairman of the Supervisory Board of Talanx AG, stated. "Dr. Wicke will be tasked with maintaining and refining the systematic process of consolidation currently ongoing within the division."
Dr. Wicke is currently a member of the Management Board of Wüstenrot & Württembergische AG, on which he serves as Chief Financial Officer and Chief Risk Officer. The 45-year-old Dr. Wicke previously served on the Management Board of DBV-Winterthur Versicherungen from 2004 to 2007, with responsibility for the areas of Finance, DBV Netherlands and International Cooperations.
Dr. Wicke studied and obtained his doctoral degree at the University of Bamberg. He is married with two children.
Disclaimer
This news release contains forward-looking statements which are based on certain assumptions, expectations and opinions of the Talanx AG management. These statements are, therefore, subject to certain known or unknown risks and uncertainties. A variety of factors, many of which are beyond Talanx AG’s control, affect Talanx AG’s business activities, business strategy, results, performance and achievements. Should one or more of these factors or risks or uncertainties materialise, actual results, performance or achievements of Talanx AG may vary materially from those expressed or implied in the relevant forward-looking statement. Talanx AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors nor does Talanx AG accept any responsibility for the actual occurrence of the forecasted developments. Talanx AG neither intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.
